Ocugen (OCGN) Cash from Operations (2014 - 2026)
Ocugen's (OCGN) quarterly Cash from Operations came in at 21794000.0 in Q1 2026, down 12.59% YoY from 24933005.79 in Q1 2025, and down 56.11% on a QoQ basis from 13961000.0 in Q4 2025.
Analysis
Ocugen (OCGN) Cash from Operations (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 13 years of Cash from Operations data on file, last reported at 21794000.0 in Q1 2026.
- Quarterly Cash from Operations fell 12.59% year-over-year to 21794000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 59401000.0 (down 16.69% YoY) and the FY2025 annual result came in at 56964000.0, down 35.17% from the prior year.
- Cash from Operations slipped to 21794000.0 in Q1 2026, from 13961000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 9911000.0 in Q2 2024 to a low of 21794000.0 in Q1 2026.
- A 5-year average of 14296058.82 and a median of 13797000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 185.18% — and 2024, when it surged 47.3%.
- Tracing OCGN's Cash from Operations over 5 years: stood at 16914000.0 in 2022, then jumped by 33.18% to 11302000.0 in 2023, then increased by 8.3% to 10364000.0 in 2024, then tumbled by 34.71% to 13961000.0 in 2025, then slumped by 56.11% to 21794000.0 in 2026.
- The last three Cash from Operations figures came in at 21794000.0 (Q1 2026), 13961000.0 (Q4 2025), and 12916000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - | -12.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.20 Mn |
| Mar 31, 2026 | -21.79 Mn |
| Dec 31, 2025 | -13.96 Mn |
| Sep 30, 2025 | -12.92 Mn |
| Jun 30, 2025 | -10.73 Mn |
| Mar 31, 2025 | -19.36 Mn |
| Dec 31, 2024 | -10.36 Mn |
| Sep 30, 2024 | -11.27 Mn |
| Jun 30, 2024 | -9.91 Mn |
| Mar 31, 2024 | -10.60 Mn |
| Dec 31, 2023 | -11.30 Mn |
| Sep 30, 2023 | -13.71 Mn |
| Jun 30, 2023 | -18.81 Mn |
| Mar 31, 2023 | -18.24 Mn |
| Dec 31, 2022 | -16.91 Mn |
| Sep 30, 2022 | -14.30 Mn |
| Jun 30, 2022 | -13.80 Mn |
| Mar 31, 2022 | -15.07 Mn |
| Dec 31, 2021 | -12.80 Mn |
| Sep 30, 2021 | -8.05 Mn |